Cargando…

Estradiol Affects Epstein–Barr Virus Reactivation-Induced Thyrotropin Receptor Antibody and Immunoglobulin Production in Graves’ Disease Patients and Healthy Controls

Epstein–Barr virus (EBV) is a gamma-herpesvirus persisting mainly in human B lymphocytes. EBV reactivation induces host cells to differentiate into plasma cells and is related to autoimmune diseases. Graves’ disease, an autoimmune hyperthyroidism, is caused by the thyrotropin receptor antibody (TRAb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hara, Sayuri, Nagata, Keiko, Kumata, Keisuke, Matsushita, Michiko, Kuwamoto, Satoshi, Kato, Masako, Hayashi, Kazuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145039/ https://www.ncbi.nlm.nih.gov/pubmed/30133352 http://dx.doi.org/10.1089/vim.2018.0032

Ejemplares similares

Subclinical Epstein-Barr Virus Primary Infection and Lytic Reactivation Induce Thyrotropin Receptor Autoantibodies
por: Tamoto, Naohiro, et al.
Publicado: (2019)

Thyrotropin Receptor Antibody (TRAb)-IgM Levels Are Markedly Higher Than TRAb-IgG Levels in Graves' Disease Patients and Controls, and TRAb-IgM Production Is Related to Epstein–Barr Virus Reactivation
por: Kumata, Keisuke, et al.
Publicado: (2016)

Epstein–Barr Virus Lytic Reactivation Activates B Cells Polyclonally and Induces Activation-Induced Cytidine Deaminase Expression: A Mechanism Underlying Autoimmunity and Its Contribution to Graves' Disease
por: Nagata, Keiko, et al.
Publicado: (2017)

Production of thyrotropin receptor antibodies in acute phase of infectious mononucleosis due to Epstein–Barr virus primary infection: a case report of a child
por: Nagata, Keiko, et al.
Publicado: (2015)

Presence of Epstein–Barr virus-infected B lymphocytes with thyrotropin receptor antibodies on their surface in Graves’ disease patients and in healthy individuals
por: Nagata, Keiko, et al.
Publicado: (2014)

SAT-555 Cytotoxicity of Epstein-Barr Virus Reactivation-Induced TRAb-IgM to Thyrocytes
por: Nagata, Keiko, et al.
Publicado: (2019)

Epstein–Barr Virus Lytic Reactivation Induces IgG4 Production by Host B Lymphocytes in Graves' Disease Patients and Controls: A Subset of Graves' Disease Is an IgG4-Related Disease-Like Condition
por: Nagata, Keiko, et al.
Publicado: (2018)

Epstein–Barr Virus Reactivation-Induced Immunoglobulin Production: Significance on Autoimmunity
por: Nagata, Keiko, et al.
Publicado: (2020)

A new in situ hybridization and immunohistochemistry with a novel antibody to detect small T-antigen expressions of Merkel cell polyomavirus (MCPyV)
por: Matsushita, Michiko, et al.
Publicado: (2014)

Aberrant expression of AID and AID activators of NF-κB and PAX5 is irrelevant to EBV-associated gastric cancers, but is associated with carcinogenesis in certain EBV-non-associated gastric cancers
por: Mohri, Takashi, et al.
Publicado: (2017)

Circulating thyrotropin is upregulated by estradiol
por: Benvenga, Salvatore, et al.
Publicado: (2018)

MON-593 Thyrotropin Receptor Stimulating Immunoglobulin: Clinical Utility in Graves' Disease Diagnosis
por: Marques, Bernardo, et al.
Publicado: (2019)

Evaluation of the diagnostic performance of thyroid‐stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease
por: Xu, Shiji, et al.
Publicado: (2023)

Thyrotropin receptor antibodies and Graves’ orbitopathy
por: Diana, T., et al.
Publicado: (2020)

Correction to: Thyrotropin receptor antibodies and Graves’ orbitopathy
por: Diana, T., et al.
Publicado: (2021)

Thyrotropin Binding Inhibiting Antibody (TBIAb) in Graves’ Disease
por: Cho, Won Yong, et al.
Publicado: (1988)

Does the Epstein–Barr Virus Play a Role in the Pathogenesis of Graves’ Disease?
por: Pyzik, Aleksandra, et al.
Publicado: (2019)

Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves’ Disease
por: Inaba, Hidefumi, et al.
Publicado: (2016)

Prospective Trial of Functional Thyrotropin Receptor Antibodies in Graves Disease
por: Kahaly, George J, et al.
Publicado: (2019)

Stimulatory Thyrotropin Receptor Antibodies Are a Biomarker for Graves’ Orbitopathy
por: George, Augustine, et al.
Publicado: (2021)

Interleukin-1 loop model for pathogenesis of Langerhans cell histiocytosis
por: Murakami, Ichiro, et al.
Publicado: (2015)

Acute-phase ITIH4 levels distinguish multi-system from single-system Langerhans cell histiocytosis via plasma peptidomics
por: Murakami, Ichiro, et al.
Publicado: (2015)

GATA2 Mediates Thyrotropin-Releasing Hormone-Induced Transcriptional Activation of the Thyrotropin β Gene
por: Ohba, Kenji, et al.
Publicado: (2011)

Cut-Off Value of Thyrotropin-Receptor Antibodies in Grave’s Disease in Basrah
por: Radhi, Maher A, et al.
Publicado: (2023)

Graves' Patient with Thymic Expression of Thyrotropin Receptors and Dynamic Changes in Thymic Hyperplasia Proportional to Graves' Disease Activity
por: Song, Young Shin, et al.
Publicado: (2016)

Hépatite auto-immune déclenchée après une hépatite aiguë grave à Epstein Barr virus
por: Montacer, Khaoula El, et al.
Publicado: (2020)

A case of methotrexate‐associated Epstein‐Barr virus‐positive mucocutaneous ulcer
por: Sakamoto, Keiko, et al.
Publicado: (2022)

Is There Diagnostic Value in Detection of Immunoglobulin G Antibodies to the Epstein–Barr Virus Early Antigen?
por: Crowley, Andrea, et al.
Publicado: (2012)

Changes in the Properties of the Thyrotropin Receptor Antibody in Patients with Graves’ Disease after Radioiodine Treatment
por: Cho, Bo Youn, et al.
Publicado: (1990)

Thyrotropin-producing pituitary adenoma simultaneously existing with Graves’ disease: a case report
por: Arai, Nobuhiko, et al.
Publicado: (2017)

Positivity of both plasma Epstein–Barr virus DNA and serum Epstein–Barr virus capsid specific immunoglobulin A is a better prognostic biomarker for nasopharyngeal carcinoma
por: Zhao, Fei-Peng, et al.
Publicado: (2014)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Characterization of Apparently Paradoxical Thyrotropin Binding Inhibitory Immunoglobulins With Neutral Bioactivity
por: Tagami, Tetsuya, et al.
Publicado: (2022)

Limiting dilution analysis of Epstein-Barr virus-induced immunoglobulin production by human B cells
Publicado: (1983)

Graves' Disease with Thymic Hyperplasia: The Response of the Thyroid Function, Thyrotropin Receptor Autoantibody, and Thymic Size to Thiamazole Treatment
por: Tsukada, Daichi, et al.
Publicado: (2022)

Merkel cell polyomavirus–negative Merkel cell carcinoma is associated with JAK‐STAT and MEK‐ERK pathway activation
por: Iwasaki, Takeshi, et al.
Publicado: (2021)

Case report of recurrent atrial fibrillation induced by thyrotropin-secreting pituitary adenoma with Graves’ disease
por: Li, Jiaqi, et al.
Publicado: (2018)

Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study
por: Pearce, Simon H.S., et al.
Publicado: (2019)

Establishment of Epstein‐Barr Virus‐positive Human Gastric Epithelial Cell Lines
por: Tajima, Masako, et al.
Publicado: (1998)

Epstein–Barr virus-associated posttransplant lymphoproliferative disorder involving the central nervous system following autologous hematopoietic stem cell transplantation for neuroblastoma
por: Sano, Hitoshi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k401eqpghhq9n16jhas6ieoso6